ORGO logo

ORGO Organogenesis Holdings Inc.

NASDAQ Capital Market · Drug Manufacturers - Specialty & Generic · Healthcare

$0.77
-0.02 (-2.23%)

Organogenesis Holdings Inc. is a U.S.-based regenerative medicine firm that specializes in creating, producing, and marketing innovative therapies for advanced wound management, as well as surgical and sports medicine applications. Within its advanced wound care portfolio, Organogenesis offers several distinct products. These include Affinity and Novachor, both amniotic membrane dressings designed…

Market Cap: $100.16Morganogenesis.com

Price

No data yet.

Social Signal Score

40
5d
—
30d
41
3 mentions
—
60d
40
5 mentions
—
90d
40
5 mentions
—
news: 5

Analyst Ratings

6 analysts
Buyconsensus
Strong Buy 0Buy 4Hold 2Sell 0Strong Sell 0
Avg price target$2.5+224.0%
Low $2Median $2.5High $3
Current Consensus

Revenue

$45.46M+74317.20%
$0.00$75.02M$150.05M$225.07M
Dec 2016Sep 2026

Analyst Estimates

FY2025
$0.15
$0.14–$0.16
1 analysts
FY2026
$-1.43-1043% YoY
$-1.50–$-1.37
1 analysts
FY2027
$-0.54
$-0.59–$-0.49
2 analysts

Consensus estimates, not results. Via Financial Modeling Prep.

Company Profile

CEO
Gary S. Gillheeney
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
854
Beta
1.27
Country
US
Piotroski score
2 / 9 (Weak)
Altman Z-score
0.42
organogenesis.com